ArticleBMC cancer2025

Peripheral blood cells predict the efficacy and prognosis of neoadjuvant immunotherapy combined with chemotherapy for esophageal squamous cell carcinoma.

Xingqiang Ran et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.